COVID-19 infection is associated with an increased risk of six newly diagnosed allergic conditions across a diverse population of children and adults, according to a retrospective cohort study published in the Annals of Allergy, Asthma & Immunology. In the full cohort evaluated over an 18-month period, researchers found significant hazard ratios for atopic dermatitis, asthma, food allergy, rhinoconjunctivitis, medication allergy, and urticaria, pointing to a broad allergic disease burden following the virus.
Evaluating Allergic Outcomes in a Propensity-Matched Cohort
Investigators utilized 1:2 propensity score matching to assess the development of incident allergic conditions among individuals aged 1 to 64 years. The analysis tracked new diagnoses during the follow-up period to calculate hazard ratios for atopic dermatitis, asthma, food allergy, rhinoconjunctivitis, medication allergy, and urticaria across the entire study population.
While the full cohort demonstrated elevated risks across respiratory, skin, food, and medication-related outcomes, separate subgroup analyses revealed distinct patterns among different demographics. Among active-duty service members, statistically significant associations were limited to asthma and rhinoconjunctivitis. In children, the infection showed a significant association with five of the six conditions, with food allergy serving as the sole exception.
Higher sponsor rank correlates with lower asthma risk
Higher sponsor rank, used in the study as a surrogate marker for socioeconomic status, correlated with a slightly lower risk of developing asthma among participants. The study authors suggested a possible mechanistic link between COVID-19 and type two inflammation, though they noted that the retrospective observational design prevents the findings from establishing direct causation or confirming the proposed inflammatory pathway.
In a nationwide cohort study published in The Journal of Allergy and Clinical Immunology, researchers including Dong Keon Yon of the Armed Force Medical Command, Republic of Korea Armed Forces and colleagues analyzed data from the Health Insurance Review & Assessment Service of Korea to examine how pre-existing allergic disorders influenced SARS-CoV-2 test positivity and clinical severity among patients tested between January 1, 2020, and May 15, 2020.
Common Questions About Post-Infection Allergic Conditions
What specific allergic conditions showed increased risk after COVID-19 infection?
The retrospective cohort study published in the Annals of Allergy, Asthma & Immunology identified increased risks for atopic dermatitis, asthma, food allergy, rhinoconjunctivitis, medication allergy, and urticaria.
How did results differ between children and active-duty service members?
In children, COVID-19 infection was significantly associated with five of the six evaluated conditions, excluding only food allergy. Among active-duty service members, statistically significant associations were observed specifically for asthma and rhinoconjunctivitis.
What data source was used for the South Korean nationwide cohort study on allergies and COVID-19 susceptibility?
Researchers evaluated data obtained from the Health Insurance Review & Assessment Service of Korea covering all adult patients aged over 20 who underwent SARS-CoV-2 testing between January 1, 2020, and May 15, 2020.
Keep reading